Frailty syndrome is marked by reduced muscle mass, tone, and strength, along with slower mobility, decreased physical activity, weight loss, fatigue, declining physiological functions, and elevated inflammatory markers. These factors increase the risk of falls, disabilities, and hospitalizations in the elderly. Given the potential of stem cells to counter or reverse many signs and symptoms of frailty, these therapies have gained significant interest as a therapeutic option.